Japan· JP-4291090F1022
イボシデニブ
A ivosidenib product containing イボシデニブ, registered in Japan by 日本セルヴィエ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- イボシデニブ
- Manufacturer
- 日本セルヴィエ
- Country
- Japan (JP)
- ATC code
- L01XX62
- ATC class
- Ivosidenib
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
516 interactions on record for ivosidenib.
Graded by severity as the source publishes them — 278 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ivosidenib · interactions on record
516 records
- 278 severe
- 223 moderate
- 15 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d128009b-b425-4d6f-ad25-41b5a2a975c9 GET /v1/drugs/d128009b-b425-4d6f-ad25-41b5a2a975c9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２５０ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "4291090F1022",
"category": "内用薬",
"price_yen": 30007.6,
"generic_name": "イボシデニブ",
"product_name_jp": null,
"therapeutic_class": "4291",
"transitional_expiry": null
}See everything about ivosidenib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.